Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor B A
Mercer's Institute for Research on Ageing, St. James's Hospital, Dublin, Ireland.
Int J Geriatr Psychiatry. 1999 Apr;14(4):280-4.
Benzodiazepines are the most commonly prescribed psychotropic drug in the elderly. Benzodiazepines with a long duration of action can produce marked sedation and psychomotor impairment in older people, and are associated with an increased risk of hip fracture and of motor vehicle crash. One thousand seven hundred and one individuals of 65 years and over, identified from General Practitioner lists, were interviewed using the Geriatric Mental State-AGECAT package and current psychotropic drug use was recorded. Benzodiazepines were classified as having a short or long elimination half-life. Two hundred and ninety-five (17.3%) individuals were taking a benzodiazepine, with use in females being twice that in males. Of the 295, 152 (51.5%) were taking a long acting benzodiazepine and the use of long acting anxiolytic type benzodiazepines was particularly common. Fifty-two (17.6%) benzodiazepine users were taking one or more other psychotropic drugs. A benzodiazepine was used by eight of 18 (44.4%) subjects with an anxiety disorder, 62 of 180 (34.4%) individuals with depression, and seven of 71 (9.9%) people with dementia. Four-fifths of older people on a psychotropic drug were taking a benzodiazepine, highlighting the importance of this class of drug in the elderly population. The choice of a benzodiazepine with a long duration of action, which have been shown to be associated with serious adverse events in the elderly in over one half of benzodiazepine users, is of concern. The potential for adverse effects was further accentuated by polypharmacy practices. The choice of benzodiazepine for an older person has important consequences and should be addressed in greater detail with primary care.
苯二氮䓬类药物是老年人中最常用的精神药物。作用时间长的苯二氮䓬类药物可在老年人中产生明显的镇静作用和精神运动障碍,并与髋部骨折和机动车碰撞风险增加有关。从全科医生名单中识别出1701名65岁及以上的个体,使用老年精神状态-AGECAT软件包进行访谈,并记录当前精神药物的使用情况。苯二氮䓬类药物被分类为具有短或长的消除半衰期。295名(17.3%)个体正在服用苯二氮䓬类药物,女性的使用量是男性的两倍。在这295名个体中,152名(51.5%)正在服用长效苯二氮䓬类药物,长效抗焦虑型苯二氮䓬类药物的使用尤为常见。52名(17.6%)苯二氮䓬类药物使用者正在服用一种或多种其他精神药物。18名焦虑症患者中有8名(44.4%)使用了苯二氮䓬类药物,180名抑郁症患者中有62名(34.4%),71名痴呆症患者中有7名(9.9%)。五分之四服用精神药物的老年人正在服用苯二氮䓬类药物,突出了这类药物在老年人群中的重要性。超过一半的苯二氮䓬类药物使用者选择了作用时间长的苯二氮䓬类药物,而这类药物已被证明与老年人的严重不良事件有关,这令人担忧。联合用药做法进一步加剧了不良反应的可能性。为老年人选择苯二氮䓬类药物具有重要影响,初级保健应更详细地加以探讨。